Jim Simons's position in Gilead Sciences is currently worth $374 Million. That's 0.57% of their equity portfolio (19th largest holding). The first Gilead Sciences trade was made in Q2 2013. Since then Jim Simons bought shares twenty more times and sold shares on 21 occasions. The investor's estimated purchase price is $411 Million, resulting in a loss of 9.0%.
In this article we take a look at Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks. Click to skip ahead and see Jim Simons Stock Portfolio: 5 Biggest...
Yahoo Finance, over 1 year agoJim Simons is the founder and hedge fund manager of Renaissance Technologies, which currently has a total portfolio value north of $77 billion, per Stock Cir...
Benzinga, over 1 year ago